首页 | 本学科首页   官方微博 | 高级检索  
     


Safety and Effectiveness of Vedolizumab in Patients with Steroid-Refractory Gastrointestinal Acute Graft-versus-Host Disease: A Retrospective Record Review
Authors:Yngvar Fløisand  Vladimir Lj Lazarevic  Johan Maertens  Jonas Mattsson  Nirav N. Shah  Pierre Zachée  Aliki Taylor  Mona Akbari  Syed Quadri  Andrejus Parfionovas  Yi-Bin Chen
Affiliation:1. Department of Hematology, Oslo University Hospital, Oslo, Norway;3. Department of Hematology, University Hospitals Leuven, Leuven, Belgium;4. Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden;5. Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin;6. Hematology Service, ZNA Stuivenberg, Antwerp, Belgium;7. Takeda Development Centre Europe Ltd, London, UK;8. Takeda Pharmaceuticals International Co., Cambridge, Massachusetts;9. Blood and Marrow Transplant Program, Massachusetts General Hospital, Boston, Massachusetts
Abstract:
Keywords:Safety  Effectiveness  Vedolizumab  Steroid-refractory gastrointestinal acute graft-versus-host disease  Retrospective record review
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号